Stereotaxis, Inc.

AMEX:STXS

Medical - Instruments & Supplies

Healthcare
$0.95 +2.53%

+$0.05 today

Market cap
$94.80M
Beta
1.32
P/E (TTM)
-8.3
EPS (TTM)
-$0.22
52W Low $1.70High $3.59

Volume 0.90M

Average 0.39M

STXS Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

Stereotaxis, Inc.AMEX: STXS

Change in Working Capital · Q1 FY2026 · quarter ended Mar 2026

Change in working capital turns negative

Q1 FY2026 change in working capital was -$838K, compared with $637K a year earlier. Trailing-twelve-month change in working capital was -$7.1M. Over 3 fiscal years it compounded at +72.1% a year.

Context

  • Change in working capital amounted to 17.4% of revenue in FY2025, up 8.1 pp from a year earlier.
  • Change in working capital increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly change in working capital holds near -$838K or moves back toward the trailing-twelve-month quarterly average of -$1.77M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$838K-48.9% QoQ
Last fiscal yearDec 2025
-$5.62M-324.4% YoY
LTMMar 2026
-$7.1M-291.1% YoY
Change in Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-231.6%——
1 year-324.4%——
3-year CAGR+72.1%——
5-year CAGR——
10-year CAGR——

Change in Working Capital history

USD · from the cash flow

Latest · FY2025
(5.62M) USD
Year-over-year change
-324.4%

Change in Working Capital vs competitors

How STXS compares with its peers on the latest reported figures

  • STXS's LTM Mar 2026 change in working capital of $7.1M is the 3rd largest of the 5 companies compared; the peer median is $5.73M.
  • Its year-over-year change of -291.1% is the 3rd highest of 5, against a peer median of -186.0%.
  • Change in working capital amounts to 22.7% of revenue for STXS, versus a peer median of 26.4%.
STXS Competitors Peer median
Change in Working Capital for STXS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SSIISS Innovations International, Inc.LTM Mar 2026$14.37M +64.7%+70.9%29.7%
CLPTClearPoint Neuro, Inc.LTM Mar 2026$9.43M -1458.4%+31.8%23.2%
STXSStereotaxis, Inc.LTM Mar 2026$7.1M -291.1%+72.1%22.7%
NPCENeuroPace, Inc.LTM Mar 2026$2.03M -71.7%-5.7%2.0%
MBOTMicrobot Medical Inc.LTM Mar 2026$1.86M -300.2%+64.1%1769.5%
Peer median (excluding STXS) $5.73M-186.0%+47.9%26.4%

Competitors are the stored peer set for STXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(10.72M)(18.29M)(20.71M)(24.05M)(21.64M)
Depreciation & Amortization106K429K595K969K1.56M
Deferred Income Tax00000
Stock-Based Compensation9.36M10.58M10.62M10.26M9.85M
Change in Working Capital135K(1.1M)612K2.51M(5.62M)
Accounts Receivables(1.89M)316K1.27M691K(2.02M)
Inventory(1.14M)(2.91M)(550K)677K(1.24M)
Accounts Payables1.43M(169K)218K758K(880K)
Other Working Capital1.73M1.66M(324K)379K(1.48M)
Other Non-Cash Items(1.83M)(25K)(256K)1.81M2.17M
Operating Cash Flow(2.95M)(8.42M)(9.14M)(8.5M)(13.69M)
Capital Expenditures(1.4M)(2.38M)(366K)(34K)(93K)
Acquisitions (Net)000108K0
Purchases of Investments0(19.72M)000
Sales of Investments0020.13M00
Other Investing Activities00000
Investing Cash Flow(1.4M)(22.09M)19.77M74K(93K)
Debt Repayment00000
Common Stock Issued547K220K81K297K14.76M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities00000
Financing Cash Flow547K220K81K297K14.76M
Effect of Forex Changes00000
Net Change in Cash(3.8M)(30.29M)10.71M(8.13M)985K
Free Cash Flow(4.34M)(10.79M)(9.51M)(8.53M)(13.78M)

Stereotaxis, Inc.

AMEX:STXS

Intrinsic Alpha fair value

Locked

Current Price

$0.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.